HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heart failure after allogeneic hematopoietic stem cell transplantation.

AbstractBACKGROUND:
Heart failure (HF) occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is rare but severe. We examine the role of pre-HSCT therapeutic exposures, conditioning regimens, pre-HSCT comorbidities, severe transplant-related complications, and post-HSCT cardiovascular risk factors in the development of heart failure after allo-HSCT.
METHODS:
A nested case-control study was designed. Cases with HF and controls matched for age, year of allo-HSCT, and length of follow-up were identified from a cohort of 2455 patients who underwent allo-HSCT between 2000 and 2011 for hematologic malignancies.
RESULTS:
Forty-two patients suffered from HF; mean age at presentation was 35 years (± 14 years) and mean time to presentation was 5 months (± 9 months) post-HSCT. The number of pre-HSCT cycles of chemotherapy was significantly greater (7 vs. 5 courses, P=0.023). Cases were significantly more likely to have severe acute GVHD (≥ grade III), hemorrhagic cystitis (≥ grade 2), and multiple severe transplant-related complications compared with controls (42.9% vs. 20.4%, P=0.008). Multivariate analysis revealed that pre-HSCT cycles of chemotherapy of ≥ 5 courses (OR=3.5, P=0.003) and two or more severe transplant-related complications (OR=3.6, P=0.003) were independently associated with HF.
CONCLUSIONS:
These results identify the individuals who are at higher risk of developing HF after allo-HSCT. We should pay more attention to these patients and more active management would be reasonable.
AuthorsXiao-Dong Mo, Lan-Ping Xu, Dai-Hong Liu, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Wei Han, Yu Wang, Feng-Rong Wang, Jing-Zhi Wang, Ting Zhao, Chen-Hua Yan, Yu-Qian Sun, Kai-Yan Liu, Xiao-Jun Huang
JournalInternational journal of cardiology (Int J Cardiol) Vol. 167 Issue 6 Pg. 2502-6 (Sep 10 2013) ISSN: 1874-1754 [Electronic] Netherlands
PMID22727962 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Topics
  • Adult
  • Case-Control Studies
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease (diagnosis, epidemiology)
  • Heart Failure (diagnosis, epidemiology)
  • Hematopoietic Stem Cell Transplantation (adverse effects, trends)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (diagnosis, epidemiology)
  • Transplantation, Homologous
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: